Flow-mediated dilatation of the radial artery for patients with CAD and CAD+DM respectively.

<p>Flow-mediated dilatation (FMD) of the radial artery at baseline and after ischemia-reperfusion (I-R) in patients with coronary artery disease (CAD) and CAD plus type 2 diabetes mellitus (CAD+DM) following administration of saline or the arginase inhibitor N^ω-hydroxy-nor-arginine (nor-NOHA). Data are presented as means and SD; *P<0.05, **P<0.01.